Before we kick off the New Year, let’s look back and highlight a few important moments for us here at 23andMe in 2018.The Power of Big DataFor some types of...

This interview is part of an occasional series of profiles introducing you to the people behind 23andMe’s compelling research. Chao Tian is a statistical geneticist, who came to 23andMe after...

In honor of the Chinese New Year, we’re taking one last look at the genetic milestones of 2013. From a Supreme Court ruling on patenting genes, to Angelina Jolie’s bold...

Each year at this time 23andMe puts together a list of the most interesting genetic findings of 2013. We’re doing that again but with a twist. We want to include...

Angelina Jolie’s revelation in the New York Times today that she had a double mastectomy after learning about her genetic risk for breast cancer focused attention on the difficult dilemma...

We know from scientific research that, in general, people don’t freak out about the results they get from personal genetic testing. When the results show an increased risk for serious...

BRCA1 and BRCA2 (BRCA1/2) mutations account for most (though not all) cases of inherited breast cancer in women. These mutations are also associated with an increased risk for ovarian cancer.In...